Moffitt Cancer Center
Obstetrics & Gynecology
Dr. Patricia L. Judson, MD
|
|
Give Review
Patricia Judson works in the field of Obstetrics & Gynecology. She attended University of Minnesota Medical School. University of Minnesota Medical School has a rank of 40 in research and a 10 in primary care She received awards:"Fellow (FACOG)" and "Fellow (FACS)". Patricia Judson is a published doctor as well. She has 57 publications published. The latest was: Importance of atypical glandular cells of uncertain significance in cervical cytologic smears.
Publications
- Micro-RNAs associated with the evolution of ovarian Cancer cisplatin resistance.
- Molecular determinants for lymph node metastasis in clinically early-stage endometrial Cancer.
- BAD-mediated apoptotic pathway is associated with human Cancer development.
- The Chinese herb polyphyllin D sensitizes ovarian Cancer cells to cisplatin-induced growth arrest.
- Bladder and bowel symptoms in cervical and endometrial Cancer survivors.
- Human Cancer cell line microRNAs associated with in vitro sensitivity to paclitaxel.
- Gene expression data reveals common pathways that characterize the unifocal nature of ovarian Cancer.
- Perifosine, an AKT inhibitor, modulates ovarian Cancer cell line sensitivity to cisplatin-induced growth arrest.
- A Phase II Trial of Docetaxel and Bevacizumab in Recurrent Ovarian Cancer within 12 Months of Prior Platinum-Based Chemotherapy.
- A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian Cancer cell growth.
- Factors associated with improved toxicity and tolerability of intraperitoneal chemotherapy in advanced-stage epithelial ovarian Cancers.
- Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173.
- Hyperthermic intraperitoneal chemotherapy With carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: A pilot study.
- The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian Cancer.
- In vitro analysis of ovarian Cancer response to cisplatin, carboplatin, and paclitaxel identifies common pathways that are also associated with overall patient survival.
- Uterine Serous Carcinoma: Increased Familial Risk for Lynch-Associated Malignancies.
- The BCL2 antagonist of cell death pathway influences endometrial Cancer cell sensitivity to cisplatin.
- A prospective, randomized trial of integrative medicine for women with ovarian Cancer.
- BAD phosphorylation determines ovarian Cancer chemo-sensitivity and patient survival.
- Solitary fibrous tumors arising from the Female pelvis.
- A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "Sandwich" method for stage III, IV, and recurrent endometrial Cancer.
- Ifosfamide, paclitaxel, and carboplatin, a novel triplet regimen for advanced, recurrent, or persistent carcinoma of the cervix: a phase II trial.
- Learning about ovarian Cancer at the time of diagnosis: video versus usual care.
- Vulvar Cancer in young women: demographic features and outcome evaluation.
- A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian Cancer.
- A prospective randomized trial of thalidomide With topotecan compared With topotecan alone in women With recurrent epithelial ovarian carcinoma.
- Routine pelvic examination during front-line chemotherapy for ovarian Cancer: should it play a role?
- CD83 gene polymorphisms increase susceptibility to human invasive cervical Cancer.
- Bevacizumab plus cyclophosphamide in heavily pretreated patients with recurrent ovarian Cancer.
- Stage II squamous cell carcinoma of the vagina in a patient With Bloom syndrome: a case report.
- Positron emission tomography and leiomyomas: clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review.
- Trends in the incidence of invasive and in situ Vulvar carcinoma.
- On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women With uterine sarcomas confined to the uterus.
- Widespread lymph node metastases in a young woman with FIGO stage IA1 squamous cervical Cancer.
- Treatment and recurrence patterns in Endometrial stromal sarcomas and the relation to c-kit expression.
- A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical Cancer.
- Hysteroscopy and cytology in endometrial Cancer.
- A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy.
- A phase II evaluation of Temozolomide in patients with recurrent epithelial ovarian Cancer.
- Preoperative detection of peripherally circulating Cancer cells and its prognostic significance in ovarian Cancer.
- Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix Cancers.
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast Cancer.
- BCL2 antagonist of cell death kinases, phosphatases, and ovarian Cancer sensitivity to cisplatin.
- Intussusception caused by metastatic cervical Cancer.
- A suspicious Vulvar mass diagnosed as a subpubic cartilaginous cyst.
- Feasibility and morbidity of using saline filled tissue expanders to reduce radiation-induced bowel injury in patients with Gynecologic malignancies.
- Radiation therapy with concomitant and adjuvant cisplatin and paclitaxel in high-risk cervical Cancer: long-term follow-up.
- Pericarditis due to Mycobacterium kansasii in a patient undergoing dialysis for chronic renal failure.
- Importance of atypical glandular cells of uncertain significance in Cervical cytologic smears.
- Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian Cancer cell lines: possible explanation for failure of combination therapy.
- Overexpression of focal adhesion kinase, a protein tyrosine kinase, in Ovarian carcinoma.
- Vaginal adenosarcoma arising from Endometriosis.
- Limitations of adjuvant radiotherapy for Uterine sarcomas spread beyond the uterus.
- Efficacy and tolerability of lower-dose topotecan in recurrent ovarian Cancer: a retrospective case review.
- Clinical features and outcomes of uterine and Ovarian carcinosarcoma.
- Sensitivity of ovarian Cancer cells to acetaminophen reveals biological pathways that affect patient survival.
Schools
University Of Minnesota Medical School
University Of California
University Of North Carolina
Procedures Preformed
- Abdominal Hysterectomy With Robotic Assistance
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- View All
Conditions Treated
- Atrophic Vaginitis
- Cancer
- Cervical Cancer
- Cervical Polyps
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Fellow (FACOG)
- Fellow (FACS)
Education
-
UCSF -
University of Minnesota Medical School
Hospital
-
Tampa General Hospital
Drug Facts
| NPI NUMBER | 1063504983 | |
| NPPES Provider LastName | JUDSON | |
| NPPES Provider FirstName | PATRICIA | |
| NPPES Provider ZIPCode | 336129416 | |
| NPPES Provider State | FL | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 130.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063504983 |
| Last Name Of The Provider | JUDSON |
| First Name Of The Provider | PATRICIA |
| View All |
Similar Doctors
|
Dr. Brian M. McNulty, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Mitchel S. Hoffman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert E. Brauner, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sachin M. Apte, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Johnathan M. Lancaster, MD |
|
|
Dr. James P. Lapolla, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Sandy B. Goodman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Robert M. Wenham, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan M. Hershberger, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mian M. Shahzad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie T. Romero, MD
This Doctor is OpenDoctor Recommended.
|